First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Plans $0.13 Quarterly Dividend

by · The Cerbat Gem

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH – Get Free Report) declared a quarterly dividend on Thursday, December 11th. Stockholders of record on Friday, December 12th will be paid a dividend of 0.1294 per share on Wednesday, December 31st. This represents a c) dividend on an annualized basis and a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, December 12th.

First Trust Nasdaq Pharmaceuticals ETF Trading Down 0.2%

Shares of NASDAQ:FTXH traded down $0.08 during midday trading on Friday, hitting $32.45. 240 shares of the stock were exchanged, compared to its average volume of 6,272. First Trust Nasdaq Pharmaceuticals ETF has a twelve month low of $23.28 and a twelve month high of $33.36. The company has a 50 day moving average price of $30.79 and a 200-day moving average price of $28.20. The stock has a market cap of $19.47 million, a P/E ratio of 14.51 and a beta of 0.54.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the business. Raymond James Financial Inc. purchased a new stake in First Trust Nasdaq Pharmaceuticals ETF in the 2nd quarter valued at approximately $57,000. Steph & Co. purchased a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF in the third quarter valued at $142,000. Bank of Montreal Can increased its position in First Trust Nasdaq Pharmaceuticals ETF by 68.2% during the 2nd quarter. Bank of Montreal Can now owns 8,221 shares of the company’s stock worth $211,000 after purchasing an additional 3,333 shares in the last quarter. Stratos Wealth Partners LTD. acquired a new position in First Trust Nasdaq Pharmaceuticals ETF in the 3rd quarter valued at about $230,000. Finally, Vivaldi Capital Management LP lifted its holdings in First Trust Nasdaq Pharmaceuticals ETF by 4.1% in the 3rd quarter. Vivaldi Capital Management LP now owns 9,790 shares of the company’s stock valued at $279,000 after purchasing an additional 384 shares in the last quarter.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

(Get Free Report)

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.

Featured Stories